270
Views
9
CrossRef citations to date
0
Altmetric
Original Article

The variation in high sensitive cardiac troponin concentration during haemodialysis treatment is not similar to the biological variation observed in stable end stage renal disease patients

, , , , , , & show all
Pages 645-652 | Received 03 May 2016, Accepted 28 Aug 2016, Published online: 05 Oct 2016

References

  • Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296–305.
  • Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of n-terminal pro-b-type natriuretic peptide, high-sensitivity c-reactive protein, and cardiac troponin t and i in end-stage renal disease for all-cause death. Clin Chem 2004;50:2279–85.
  • Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin i and t for subsequent death in end-stage renal disease. Circulation 2002;106:2941–5.
  • Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin t and i among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005;112:3088–96.
  • Needham DM, Shufelt KA, Tomlinson G, Scholey JW, Newton GE. Troponin i and t levels in renal failure patients without acute coronary syndrome: a systematic review of the literature. Canadian J Cardiol 2004;20:1212–18.
  • Hassan HC, Howlin K, Jefferys A, Spicer ST, Aravindan AN, Suryanarayanan G, Hall BM, Cleland BD, Wong JK, Suranyi MG, Makris A. High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population. Clin Chem 2014;60:389–98.
  • Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551–67.
  • Nice clinical guideline 95: Chest pain of recent onset. Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. National Institute for Health and Clinical Excellence. 2010. Available from: http://www.nice.org.uk/guidance/cg95
  • Aakre KM, Roraas T, Petersen PH, Svarstad E, Sellevoll H, Skadberg O, Sæle K, Sandberg S. Weekly and 90-minute biological variations in cardiac troponin t and cardiac troponin i in hemodialysis patients and healthy controls. Clin Chem 2014;60:838–47.
  • Mbagaya W, Luvai A, Lopez B. Biological variation of cardiac troponin in stable haemodialysis patients. Ann Clin Biochem 2015;52:562–8.
  • Assa S, Gansevoort RT, Westerhuis R, Kobold AC, Voors AA, de Jong PE, Bakker SJ, Franssen CF. Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin i measured by sensitive assay in hemodialysis patients. Clin Res Cardiol 2013;102:439–45.
  • Conway B, McLaughlin M, Sharpe P, Harty J. Use of cardiac troponin t in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis. Nephrol Dial Transplant 2005;20:2759–64.
  • Farkouh ME, Robbins MJ, Zafar MU, Shimbo D, Davidson KW, Puttappa R, Winston J, Halperin JL, Epstein EM, Patel M, Talor Z, Chesebro JH. Association between troponin i levels and mortality in stable hemodialysis patients. Am J Med 2003;114:224–6.
  • Lippi G, Tessitore N, Montagnana M, Salvagno GL, Lupo A, Guidi GC. Influence of sampling time and ultrafiltration coefficient of the dialysis membrane on cardiac troponin i and t. Arch Pathol Lab Med 2008;132:72–6.
  • Mongeon FP, Dorais M, Lorier JL, Froment D, Letendre E, Rinfret S. Effect of hemodialysis, coronary artery disease and diabetes on cardiac troponin t: a prospective survey over one year. Open Cardiovasc Med J 2009;3:69–77.
  • Montagnana M, Lippi G, Tessitore N, Salvagno GL, Targher G, Gelati M, Lupo A, Guidi GC. Effect of hemodialysis on traditional and innovative cardiac markers. J Clin Lab Anal 2008;22:59–65.
  • Tun A, Khan IA, Win MT, Hussain A, Hla TA, Wattanasuwan N, Vasavada BC, Sacchi TJ. Specificity of cardiac troponin i and creatine kinase-mb isoenzyme in asymptomatic long-term hemodialysis patients and effect of hemodialysis on these cardiac markers. Cardiology 1998;90:280–5.
  • Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D. Cardiac troponin t and i in end-stage renal failure. Clin Chem 2000;46:1345–50.
  • Cardinaels EP, Cornelis T, van der Sande FM, Leunissen KM, van Dieijen-Visser MP, Mingels AM, Kooman JP, Bekers O. Acute effects of conventional and extended hemodialysis and hemodiafiltration on high-sensitivity cardiac troponins. Clin Chem Lab Med 2015;53:e289–92.
  • Bartlett WA, Braga F, Carobene A, Coskun A, Prusa R, Fernandez-Calle P, Røraas T, Jonker N, Sandberg S. A checklist for critical appraisal of studies of biological variation. Clin Chem Lab Med 2015;53:879–85.
  • Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, Giannitsis E, Gustafson S, Handy B, Katus H, Melanson SE, Panteghini M, Venge P, Zorn M, Jarolim P, Bruton D, Jarausch J, Jaffe AS. Multicenter analytical evaluation of a high-sensitivity troponin t assay. Clin Chim Acta 2011;412:748–54.
  • Krintus M, Kozinski M, Boudry P, Capell NE, Koller U, Lackner K, Lefèvre G, Lennartz L, Lotz J, Herranz AM, Nybo M, Plebani M, Sandberg MB, Schratzberger W, Shih J, Skadberg Ø, Chargui AT, Zaninotto M, Sypniewska G. European multicenter analytical evaluation of the abbott architect stat high sensitive troponin i immunoassay. Clin Chem Lab Med 2014;52:1657–65.
  • Burnett RW. Accurate estimation of standard deviations for quantitative methods used in clinical chemistry. Clin Chem 1975;21:1935–8.
  • Reed AH, Henry RJ, Mason WB. Influence of statistical method used on the resulting estimate of normal range. Clin Chem 1971;17:275–84.
  • Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409–37.
  • Carlsen S, Petersen PH, Skeie S, Skadberg O, Sandberg S. Within-subject biological variation of glucose and hba(1c) in healthy persons and in type 1 diabetes patients. Clin Chem Lab Med 2011;49:1501–7.
  • Fokkema MR, Herrmann Z, Muskiet FA, Moecks J. Reference change values for brain natriuretic peptides revisited. Clin Chem 2006;52:1602–3.
  • Hyltoft Petersen P, Feldt-Rasmussen U, Horder M, Blaabjerg O, Thygesen K. Variability of plasma proteins according to molecular size. Long-term and short-term intra-individual variation. Scand J Clin Lab Invest 1981;41:143–50.
  • Nielsen H, Petersen PH, Feldt-Rasmussen U, Binder V. Variations in plasma protein concentrations in individuals with ulcerative colitis: analytical and biological factors. Scand J Clin Lab Invest 1979;39:495–502.
  • Felding P, Tryding N, Hyltoft Petersen P, Horder M. Effects of posture on concentrations of blood constituents in healthy adults: practical application of blood specimen collection procedures recommended by the scandinavian committee on reference values. Scand J Clin Lab Invest 1980;40:615–21.
  • Fahim MA, Hayen AD, Horvath AR, Dimeski G, Coburn A, Tan KS, Johnson DW, Craig JC, Campbell SB, Hawley CM. Biological variation of high sensitivity cardiac troponin-t in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med 2015;53:715–22.
  • Frankenstein L, Wu AH, Hallermayer K, Wians FH Jr, Giannitsis E, Katus HA. Biological variation and reference change value of high-sensitivity troponin t in healthy individuals during short and intermediate follow-up periods. Clin Chem 2011;57:1068–71.
  • Frankenstein L, Remppis A, Giannitis E, Frankenstein J, Hess G, Zdunek D, Doesch A, Zugck C, Katus HA. Biological variation of high sensitive troponin t in stable heart failure patients with ischemic or dilated cardiomyopathy. Clin Res Cardiol 2011;100:633–40.
  • Goldberg J, Iriarte B, Prostko J, Frias E, Ravalico T, Hebbar S. Short and long-term biological variability of troponin i determined using the architect stat high sensitive troponin i assay. Clin Chem 2011;57:C-04.
  • Nordenskjold AM, Ahlstrom H, Eggers KM, Frobert O, Jaffe AS, Venge P, Lindahl B. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem 2013;59:401–9.
  • Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin t assay. Clin Chem 2010;56:1086–90.
  • van Berkel M, Dekker MJ, Bogers H, Geerse DA, Konings CJ, Scharnhorst V. Diagnosis of acute myocardial infarction in hemodialysis patients may be feasible by comparing variation of cardiac troponins during acute presentation to baseline variation. Clin Chim Acta 2016;456:36–41.
  • Aakre KM, Langlois MR, Barth JH, Misra S, Watine J, Oosterhuis WP. The quality of laboratory aspects of troponin testing in clinical practice guidelines and consensus documents needs to be improved. Clin Chim Acta 2014;437:58–61.
  • Apple FS, Jaffe AS. Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin t assay: user beware. Clin Chem 2012;58:1599–600.
  • Hammarsten O, Jacobsson CE, Widegren M, Danylchenko T, Jaffe AS. Long-time quality assessment of the elecsys troponin t hs assay. Clin Biochem 2013;46:1055–7.
  • Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8–12.
  • Oosterhuis WP, Sandberg S. Proposal for the modification of the conventional model for establishing performance specifications. Clin Chem Lab Med 2015;53:925–37.
  • Klinkenberg LJ, van Dijk JW, Tan FE, van Loon LJ, van Dieijen-Visser MP, Meex SJ. Circulating cardiac troponin t exhibits a diurnal rhythm. J Am Coll Cardiol 2014;63:1788–95.
  • Gaze DC, Collinson PO. Cardiac troponin i but not cardiac troponin t adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: Explanation for lower serum ctni concentrations following dialysis. Open Heart 2014;1:e000108.
  • Jacobs LH, van de Kerkhof J, Mingels AM, Kleijnen VW, van der Sande FM, Wodzig WK, Kooman JP, van Dieijen-Visser MP. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin t and commercial cardiac troponin t and cardiac troponin i assays. Ann Clin Biochem 2009;46:283–90.
  • Roraas T, Petersen PH, Sandberg S. Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals. Clin Chem 2012;58:1306–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.